Studies have shown that GLP-1R expression exists in human prostate cancer and that GLP-1RA can effectively inhibit the growth of prostate cancer, so activation of GLP-1R may be a potential way to treat prostate cancer. This evidence concerns the gene GLP1R and prostate carcinoma.